The temporary closure by Alphamin of a large tin mine in the DRC has seen tin prices jump to eight-month highs of US$34,815 a ...

A DRC cobalt export ban may only impact prices in the short term, but could point to a broader price control strategy to come ...

Morgans analyst Scott Power notes there's a risk-off sentiment among investors as ASX health stocks fall again this week.

Donald Trump’s tariff war isn’t just an economic misstep, it’s a self-imposed disaster that threatens to redefine America’s ...

With a large resource and installed infrastructure, Barton Gold has lofty ambitions to become the crow-eater version of ...

Idiopathic pulmonary fibrosis is a progressive and life-threatening lung disease but there are ASX companies bringing hope to ...

Dumpster diving' for small-cap opportunities is only for the bold, but the exercise can produce some tasty morsels at a knock ...

Goldman Sachs analysts say Rio Tinto presents better growth and free cash flow potential in the years to come than BHP as ...

Austin Metals' is getting ready to explore exciting WA gold targets next door to bolter Caprice Resources' high grade Island ...

Recce has opted to carry out its phase III diabetic foot injury trial in Indonesia - which looks a safer bet than the US ...

The ASX bounced back with miners driving the rally, US shutdown fears eased, and Myer and Liontown had a solid run.

Proteomics International aptly has chosen World Kidney Day to launch its predictive test for diabetic kidney disease locally.